Real‐world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK ‐based electronic health records database-Reference-Cited by-同舟云学术

Real‐world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK ‐based electronic health records database

Published:2020-11-21 Issue:2 Volume:30 Page:248-256
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Seesaghur Anouchka¹,Petruski‐Ivleva Natalia²,Banks Victoria¹³,Wang Jocelyn Ruoyi²,Mattox Pattra²,Hoeben Edwin¹,Maskell Joe¹,Neasham David¹,Reynolds Shannon L.²,Kafatos George¹

Affiliation:

1. Department Center for Observational Research Amgen Ltd Uxbridge UK

2. Department Science Aetion, Inc Boston Massachusetts USA

3. VLB Contractors Ltd Kent UK

Funder

Amgen

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5171

Reference36 articles.

1. Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe

2. Real-World Evidence — What Is It and What Can It Tell Us?

3. Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.

4. Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

5. WangSV SchneeweissS. Improving Transparency and Replicability of Healthcare Databases to Increase Credibility of “Real World” Evidence. BMJ Opinion.https://blogs.bmj.com/bmj/2017/12/15/improving-transparency-and-replicability-of-healthcare-databases-to-increase-credibility-of-real-world-evidence/. December 15 2017. Accessed November 8 2019.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review;Pharmacoepidemiology and Drug Safety;2024-05

2. Medicine utilization studies in Australian individual‐level dispensing data: A blinded, multi‐center replicated analysis;Pharmacoepidemiology and Drug Safety;2024-03

3. Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate;Allergy and Asthma Proceedings;2023-07-16

4. Impact of Season and Other Factors on Initiation, Discontinuation, and Switching of Systemic Drug Therapy in Patients with Psoriasis: A Retrospective Study;JID Innovations;2023-03

5. Global real-life analysis of survival and usage of therapies in multiple myeloma;2023-02-23